Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Interferon-? liposome: a new system to improve drug delivery in the treatment of lung cancer
Maysa Alhawmdeh, Mohammad Isreb, Abid Aziz, Badie K. Jacob, Diana Anderson, Mojgan Najafzadeh
ERJ Open Res, 7 (3) 00555-2020; 10.1183/23120541.00555-2020
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Maysa Alhawmdeh, Mohammad Isreb, Abid Aziz, Badie K. Jacob, Diana Anderson, Mojgan Najafzadeh. Interferon-? liposome: a new system to improve drug delivery in the treatment of lung cancer. ERJ Open Res, 7 (3) 00555-2020; 10.1183/23120541.00555-2020
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Are biphosphonates efficient in the adjuvant treatment of lung cancer?
Source: Eur Respir J 2006; 28: Suppl. 50, 754s
Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing?
Source: Eur Respir J 2014; 44: 1011-1022
Does the incorporation of new generation cytotoxic agent improve the overall outcome in inoperable nonsmall cell lung cancer (NSCLC)?
Source: Eur Respir J 2003; 22: Suppl. 45, 64s
Pulmonary surfactant as drug delivery system to target lung epithelium: new approach for the treatment of epithelial injury after bleomycin challenge
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Systemic therapy. non small cell lung cancer stage I and II: treatment standards and new development
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Targeted therapies for lung cancer: how did the game begin?
Source: Breathe 2016; 12: 177-179
Immunotherapy (as an adjuvant therapeutic tool) of tuberculosis - does it have a future?
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Precision medicine for lung cancer: new targeted treatments
Source: International Congress 2017 – Precision medicine approaches in lung cancer
30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator?
Source: ERJ Open Res, 4 (4) 00030-2018; 10.1183/23120541.00030-2018
Innovative local therapies in lung cancer
Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Inhaled solid lipid nanoparticles as a new tool for drug delivery in the lung
Source: Annual Congress 2009 - New drugs for airways disease
Aerosol delivery of chemotherapy in an orthotopic model of lung cancer
Source: Annual Congress 2005 - Chemotherapy and palliative care
Lung cancer: does age affect treatment strategy?
Source: Eur Respir Mon; 2009: 43:306–326
Advances in target therapy in lung cancer
Source: Eur Respir Rev 2015; 24: 23-29
Advances in target therapy for lung cancer
Source: International Congress 2014 – Ceremony for the ERS Romain Pauwels Research Award 2014 - Clinical Year in Review I
Checkpointinhibition in lung cancer – already standard of care in any line of therapy?
Source: International Congress 2017 – Lung cancer immunotherapy
Advances in treatment of complex lung disease: will targeted therapy with anticalins be clinically applied in the near future?
Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments
Nurse led lung cancer diagnostic/supportive follow up clinic;a different approach to optimise lung cancer pathway
Source: International Congress 2018 – The many facets of respiratory nursing